Radiología y medicina física en procesos oncológicos

Mitjavila M, Jimenez Fonseca P, Bello P, Pubul V, Percovich JC, Garcia Burillo A, et al. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study. Eur J Nucl Med Mol Imaging. 2023; 50(8): 2486-2500. DOI:10.1007/s00259-023-06166-8.

Borque Fernando A, Calleja Hernandez MA, Cozar Olmo JM, Gomez Iturriaga A, Perez Fentes DA, Puente Vazquez J, et al. A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer. Actas Urol Esp. 2023; 47(2): 111-126. DOI:10.1016/j.acuro.2022.12.004.

Gear J, Stokke C, Terwinghe C, Gnesin S, Sandstroem M, Tran Gia J, et al. EANM enabling guide: how to improve the accessibility of clinical dosimetry. Eur J Nucl Med Mol Imaging. 2023; 50(7): 1861-1868. DOI:10.1007/s00259-023-06226-z.

Gabina PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, et al. Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry. Eur J Nucl Med Mol Imaging. 2023; 50(9): 2595-2604. DOI:10.1007/s00259-023-06215-2.

Gabina PM, Fuertes TM, Jauregui I, del Amo C, De Zarate E, Gustafsson J. Activity recovery for differently shaped objects in quantitative SPECT. Phys Med Biol. 2023; 68(12). DOI:10.1088/1361-6560/acd982.

Nagore G, Moreno Olmedo E, Suárez Gironzini V, Aakki L, Li RG, Gómez E, et al. Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer. Radiother Oncol. 2023; 186. DOI:10.1016/j.radonc.2023.109807.

Borque Fernando A, Calleja Hernandez MA, Cozar Olmo JM, Gomez Iturriaga A, Perez Fentes DA, Puente Vazquez J, et al. Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply. Actas Urol Esp. 2023; 47(6): 392-393. DOI:10.1016/j.acuro.2023.04.007.

Gear J, Stokke C, Terwinghe C, Gnesin S, Sandstrom M, Tran Gia J, et al. EANM enabling guide: how to improve the accessibility of clinical dosimetry (vol 50, pg 1861, 2023). Eur J Nucl Med Mol Imaging. 2023; 50(10): 3157-3158. DOI:10.1007/s00259-023-06304-2.

Monserrat Fuertes T, Santos Zorrozua B, Rodeno Ortiz de Zarate E, Peinado Montes MA, Vigil Diaz C, Minguez Gabina P. Individualisation of radiation protection recommendations for patients treated with [¹⁷⁷Lu]Lu-DOTA-TATE. EJNMMI Phys. 2023; 10(1): 50-50. DOI:10.1186/s40658-023-00570-7.

Saez J, Bar Deroma R, Bogaert E, Cayez R, Chow T, Clark CH, et al. Universal evaluation of MLC models in treatment planning systems based on a common set of dynamic tests. Radiother Oncol. 2023; 186. DOI:10.1016/j.radonc.2023.109775.

Dal Pra A, Dirix P, Khoo V, Carrie C, Cozzarini C, Fonteyne V, et al. ESTROACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer. Clin Transl Radiat Oncol. 2023; 41: 100638-100638. DOI:10.1016/j.ctro.2023.100638.

Sanmamed N, Gomez Rivas J, Buchser D, Montijano M, Gomez Aparicio MA, Duque Santana V, et al. Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?. Clinical Genitourinary Cancer. 2023. DOI:10.1016/j.clgc.2023.08.002.

Dirix P, Dal Pra A, Khoo V, Carrie C, Cozzarini C, Fonteyne V, et al. ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy. Clin Transl Radiat Oncol. 2023; 43: 100684-100684. DOI:10.1016/j.ctro.2023.100684.

Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte F, et al. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. 2023. DOI:10.1016/j.euo.2023.09.007.

Rades D, Staackmann C, Lomidze D, Jankarashvili N, Lopez F, Navarro A, et al. Radiotherapy for Metastatic Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial. Int J Radiat Oncol Biol Phys. 2023; 117(2S): 74-74. DOI:10.1016/j.ijrobp.2023.06.386.

Iglesias Hidalgo G, Lopez Maseda A, Zaldumbide Duenas L, Canteli Padilla B. Granular cell tumor of soft tissues: MR findings. Radiologia (Engl Ed). 2023; 65 Suppl 2: 83-87. DOI:10.1016/j.rxeng.2022.12.008.

Pernas RO, Canton GF, Aguirre NH, Arroita MA. Direct MR arthrography of the hip joint: anterior approach without imaging guidance. Skeletal Radiol. 2023. DOI:10.1007/s00256-023-04482-6.

Gomez Iturriaga A, Zaragoza L, Valverde I, Perez Azorin F, Santos Zorrozua B, Guerrero JA, et al. Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach. Radiother Oncol. 2023; 190. DOI:10.1016/j.radonc.2023.110024.

Gomez Aparicio MA, Lopez Campos F, Pelari Mici L, Buchser D, Pastor J, Maldonado X, et al. Bone health and therapeutic agents in advanced prostate cancer. Front Biosci. 2022; 27(1). DOI:10.31083/j.fbl2701034.

Wagstaff P, Gabina PM, Minguez R, Roeske JC. Alpha particle microdosimetry calculations using a shallow neural network. Phys Med Biol. 2022; 67(2). DOI:10.1088/1361-6560/ac499c.

Gleisner KS, Chouin N, Gabina PM, Cicone F, Gnesin S, Stokke C, et al. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands. Eur J Nucl Med Mol Imaging. 2022; 49(6): 1778-1809. DOI:10.1007/s00259-022-05727-7.

Gomez Iturriaga A, Keyes M, Martin J, Spratt DE. Should brachytherapy be added to external beam radiotherapy for prostate cancer?. Lancet Oncol. 2022; 23(1): 23-25. DOI:10.1016/S1470-2045(21)00406-X.

Achard V, Jaccard M, Vanhoutte F, Siva S, Heikkila R, Dirix P, et al. Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. Radiother Oncol. 2022; 172: 1-9. DOI:10.1016/j.radonc.2022.04.020.

Rades D, Cacicedo J, Lomidze D, Al Salool A, Segedin B, Groselj B, et al. A new and easy-to-use survival score for patients irradiated for metastatic epidural spinal cord compression. Pract Radiat Oncol. 2022; 12(4): 354-362. DOI:10.1016/j.prro.2022.03.012.

Rades D, Cacicedo J, Lomidze D, Al Salool A, Segedin B, Groselj B, et al. Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression-An Additional Analysis of Patients from Two Prospective Trials. Cancers (Basel). 2022; 14(10). DOI:10.3390/cancers14102547.

Cruz R, Almeida SD, Heredia ML, Quintela I, Ceballos FC, Pita G, et al. Novel genes and sex differences in COVID-19 severity. Hum Mol Genet. 2022. DOI:10.1093/hmg/ddac132.

Azorin JFP, Saez J, Garcia LIR, Hernandez V. Investigation on the impact of the leaf trailing effect using the Halcyon integrated platform system. Med Phys. 2022; 49(9): 6161-6170. DOI:10.1002/mp.15833.

Lara PC, Rodriguez Melcon JI, Palacios Eito A, Lozano A, Hervas Moron A, Villafranca E, et al. Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer. Front Oncol. 2022; 12: 891886-891886. DOI:10.3389/fonc.2022.891886.

Espejo Nino JM. Right ventricular metastasis from rhabdomyosarcoma. Revista Espanola De Medicina Nuclear E Imagen Molecular. 2022; 41 Suppl 1: 37-38. DOI:10.1016/j.remnie.2022.02.005.

Rades D, Segedin B, Schild SE, Lomidze D, Veninga T, Cacicedo J. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy. Radiat Oncol. 2022; 17(1). DOI:10.1186/s13014-022-02117-z.

Rades D, Al Salool A, Staackmann C, Cremers F, Cacicedo J, Lomidze D, et al. A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression. Cancers (Basel). 2022; 14(15). DOI:10.3390/cancers14153827.

Pouget J, Konijnenberg M, Eberlein U, Glatting G, Gabina PM, Herrmann K, et al. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. Eur J Nucl Med Mol Imaging. 2023; 50(2): 242-246. DOI:10.1007/s00259-022-05934-2.

Cacicedo J, Casquero F, Navarro A, Martinez Indart L, Del Hoyo O, Frias A, et al. Prospective multicentre analysis of the therapeutic approach and prognostic factors determining overall survival in elderly patients with non-small-cell lung carcinoma treated with curative intent. Bjr Open. 2022; 4(1): 20210058-20210058. DOI:10.1259/bjro.20210058.

Rades D, Zwaan I, Cacicedo J, Bruchhage KL, Hakim SG, Olbrich D, et al. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02). BMC Cancer. 2022; 22(1): 989-989. DOI:10.1186/s12885-022-10088-3.

Gomez Iturriaga A, Buchser D, Marban M, Miguel IS, Raton I, Cacicedo J, et al. Use Of Value-Based-Healthcare To Evaluate A Novel Treatment Protocol For Localized Prostate Cancer. Radiother Oncol. 2022; 170: 814-815

Garcia RI, Jauregui I, Del Amo C, Gandiaga A, Rodriguez O, Margallo L, et al. Implementation of an In-House 3D Manufacturing Unit in a Public Hospital's Radiology Department. Healthcare. 2022; 10(9). DOI:10.3390/healthcare10091791.

Valverde Jorge R, Fernandez Tercero I, Jimenez M, Jauregui Garcia M, Genolla Subirats J, Rodeno Ortiz de Zarate E. Descending mediastinitis mimicking a pharyngo-laryngeal neoplasia. Revista Espanola De Medicina Nuclear E Imagen Molecular. 2022. DOI:10.1016/j.remnie.2022.09.009.

Canon V, Gomez Iturriaga A, Casquero F, Rades D, Navarro A, Del Hoyo O, et al. Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy. Rep Pract Oncol Radiother. 2022; 27(3): 428-439. DOI:10.5603/RPOR.a2022.0048.

Cacicedo J, Inhiesto EG, Ayesta MTA, Ustarroz I, Rades D. Evaluation of results and costs of high precision radiotherapy (VMAT) compared with conventional radiotherapy (3D) in the treatment of cancer patients with spinal cord compression of metastatic origin. Rep Pract Oncol Radiother. 2022; 27(4): 610-614. DOI:10.5603/RPOR.a2022.0068.

Zilli T, Achard V, Dal Pra A, Schmidt Hegemann N, Alicja Jereczek Fossa B, Lancia A, et al. Recommendations for Radiation Therapy in Oligometastatic Prostate Cancer: an ESTRO-ACROP Delphi consensus. Radiother Oncol. 2022; 176: 199-207. DOI:10.1016/j.radonc.2022.10.005.

Algara M, Rodriguez E, Martinez Arcelus FJ, Salinas J, Sanz X, Beato I, et al. OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial. Radiother Oncol. 2022; 176: 76-82. DOI:10.1016/j.radonc.2022.09.006.

Fuertes TM, Iglesias NM, Olmedo DJ, Sanchez CA, Llorente DA, Montes MP, et al. Proposal of a Simple Method to Establish Individualized Restriction Times after Medical Discharge in Treatments with Lu-177-DOTATATE. Eur J Nucl Med Mol Imaging. 2022; 49(SUPPL 1): 627-628

Gabina PM, Fuertes TM, Jorge RV, Figueruelo AE, Veganzones MM, Munoz RN, et al. Effective-doses received by partners of patients treated with Lu-177-DOTATATE. Eur J Nucl Med Mol Imaging. 2022; 49(SUPPL 1): 629-629

Mitjavila Casanovas M, Bello P, Pubul V, Garcia Burillo A, Hernando J, Alonso Farto J, et al. Lu-177-DOTATATE therapy in advanced pancreatic neuroendocrine tumors: data from 187 patients of the national registry SEPTRALU. Eur J Nucl Med Mol Imaging. 2022; 49(SUPPL 1): 247-247

Nunez Munoz R, Ortega YC, Sarmiento M, Jorge RV, Fuentes AP, Subirats JG, et al. Stimulated thyroglobulin ( TG) prior to [131I] therapy (RAIT) in patients with differentiated thyroid cancer (DTC) as a predictive factor of recurrence. Eur J Nucl Med Mol Imaging. 2022; 49(SUPPL 1): 586-586

Gutiérrez Zurimendi G, García de Casasola Rodríguez G, Urrestizala Peña I, Aizcorbe Gómez M, Maldonado De Sasia A, Urresola Olabarrieta A. Carcinoma renal de ductos colectores de Bellini: presentación de dos casos y revisión de la literatura. Revista Mexicana De Urología. 2022; 82(1): 9-9. DOI:10.48193/revistamexicanadeurologa.v82i1.730.

Espejo Nino JM. Right ventricular metastasis from rhabdomyosarcoma. Rev Esp Med Nucl Imagen Mol. 2022; 41: 37-38. DOI:10.1016/j.remn.2021.05.002.

Espejo Nino J, Astudillo Sarmiento M, Valverde Jorge R, Pena Fuentes A, Rodeno Ortiz de Zarate E. Unicentric results in sentinel lymph node biopsy (SLNB) in patients with locally advanced breast cancer (LABC). Eur J Nucl Med Mol Imaging. 2022; 49(SUPPL 1): 531-532

Dickson JC, Armstrong IS, Gabina PM, Denis Bacelar AM, Krizsan AK, Gear JM, et al. EANM practice guideline for quantitative SPECT-CT. Eur J Nucl Med Mol Imaging. 2023; 50(4): 980-995. DOI:10.1007/s00259-022-06028-9.

Romero R, de la Fuente L, Del Pozo Valero M, Riveiro Alvarez R, Trujillo Tiebas MJ, Martin Merida I, et al. An evaluation of pipelines for DNA variant detection can guide a reanalysis protocol to increase the diagnostic ratio of genetic diseases. npj Genom Med. 2022; 7(1). DOI:10.1038/s41525-021-00278-6.

Rades D, Cacicedo J, Conde Moreno AJ, Segedin B, Lomidze D, Ciervide R et al. Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials. Radiat Oncol. 2021; 16(1). DOI:10.1186/s13014-020-01737-7.

Henriquez I, Spratt D, Gomez Iturriaga A, Abuchaibe O, Counago F. Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease. World J Clin Oncol. 2021; 12(1): 6-12. DOI:10.5306/wjco.v12.i1.6.

Cacicedo J, Mendizabal N, Arietaleanizbeaskoa MS. Letter to the editor referencing "Body composition changes in patients with head and neck cancer under active treatment: a scoping review". Support Care Cancer. 2021; 30(1): 1-2. DOI:10.1007/s00520-021-05999-z.

Garcia LIR, Perez Azorin JF, Anguiano M, Lallena AM. Monte Carlo calculation of charge collection efficiencies in ionization chambers. Phys Med Biol. 2021; 66(4). DOI:10.1088/1361-6560/abd4f8.

Mayrata E, Espinosa JM, Buchser D, Casquero F, Suarez F, Gonzalez A et al. Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control. J Contemp Brachytherapy. 2021; 13(1): 12-17. DOI:10.5114/jcb.2021.103581.

Fuertes TM, Gonzalez Garcia FM, Peinado Montes MA, Dominguez Grande ML, Martin Fernandez N, Gomez de Iturriaga Pina A et al. Description of the methodology for dosimetric quantification in treatments with 177Lu-DOTATATE. Rev Esp Med Nucl Imagen Mol. 2021; 40(3): 167-178. DOI:10.1016/j.remn.2021.02.006.

Perea Romero I, Gordo G, Iancu IF, Del Pozo Valero M, Almoguera B, Blanco Kelly F et al. Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications. Sci Rep. 2021; 11(1): 10340-10340. DOI:10.1038/s41598-021-89275-4.

Gutierrez Zurimendi G, Zabala Egurrola JA, Lecumberri Castanos D, Urresola Olabarrieta A, Ezquerro Imas AI, Cambon Baston EM et al. Orthotopic kidney transplantation (ORT): an alternative when heterotopic is not possible. Arch Esp Urol. 2021; 74(3): 293-298

Sherer MV, Lin D, Elguindi S, Duke S, Tan L, Cacicedo J et al. Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review. Radiother Oncol. 2021; 160: 185-191. DOI:10.1016/j.radonc.2021.05.003.

Segundo CG, Counago F, Gomez Iturriaga A. Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on. Urol Oncol-Semin Orig Investig. 2021; 39(6): 351-356. DOI:10.1016/j.urolonc.2021.02.012.

Minguez P, Genolla J, Dominguez M, Exposito A, Santos B, Rodeno E. Dependency of the remnant 131I-NaI biokinetics on the administered activity in patients with differentiated thyroid cancer. Phys Medica. 2021; 88: 45-52. DOI:10.1016/j.ejmp.2021.06.012.

Gomez Iturriaga A. For the motion rebuttal. Radiother Oncol. 2021; 158: 20-20

Gomez Aparicio MA, Valero J, Caballero B, Garcia R, Hernando Requejo O, Montero A et al. Extreme Hypofractionation with SBRT in Localized Prostate Cancer. Curr Oncol. 2021; 28(4): 2933-2949. DOI:10.3390/curroncol28040257.

Cacicedo J, Ciria JP, Morillo V, Martinez Indart L, Gomez Iturriaga A, del Hoyo O et al. Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study (vol 64, pg 859, 2020). J Med Imag Radiat Oncol. 2021; 65(6): 829-829. DOI:10.1111/1754-9485.13321.

Buchser D, Medina R, Mayrata E, Gonzalez A, Marban M, Achard V et al. Salvage local treatment for localized radio-recurrent prostate cancer: a narrative review and future perspectives. Future Oncol. 2021; 17(31): 4207-4219. DOI:10.2217/fon-2021-0320.

Zapatero A, Roch M, Castro Tejero P, Buchser D, Martin de Vidales C, Gonzalez S et al. MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial. Br J Radiol. 2021; 95(1131): 20210683-20210683. DOI:10.1259/bjr.20210683.

Dominguez Ayala M, Minguez Gabina P, Paja Fano M, Bilbao Gonzalez A, Exposito Rodriguez A, Rodeno Ortiz de Zarate E. The role of BRAF V600E mutation in post-surgical 131I therapy in papillary thyroid carcinoma. A study based on SPECT-CT uptake analysis. Q J NUCL MED MOL IM. 2021. DOI:10.23736/S1824-4785.21.03343-4.

Lopez Campos F, Cacicedo J, Counago F, Garcia R, Leaman Alcibar O, Navarro Martin A et al. SEORSBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis. Clin Transl Oncol. 2021; 24(2): 215-226. DOI:10.1007/s12094-021-02695-6.

Conde Moreno AJ, Lopez F, Hervas A, Morillo V, Mendez A, Puertas MDM et al. Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021; 111(3S): 59-59. DOI:10.1016/j.ijrobp.2021.07.151.

del Campo ER, De Bobadilla JCF, Valentini C, Andratschke N, Mohamed W, Abrunhosa Branquinho A et al. The elephant in the room: teaching OAR delineation in a FALCON workshop in the autosegmentation era. Radiother Oncol. 2021; 161: 1255-1256

Rades D, Staackmann C, Lomidze D, Jankarashvili N, Navarro A, Lopez F et al. Higher-dose radiotherapy for metastatic spinal cord compression: First results of a phase II trial. Radiother Oncol. 2021; 161: 303-304

Valentini C, Cacicedo J, Luis J, Arrojo E, Lancellotta V, Matias A et al. Does online learning in delineation thrive during a Pandemic? The FALCON group experience. Radiother Oncol. 2021; 161: 1249-1250

Lopez Campos F, Lorente D, Perez CL, Ramirez Backhaus M, Peleteiro P, Gomez Iturriaga A et al. Evaluation of PSA progression after initiation of enzalutamide or abiraterone: Real-world data on metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2021; 39(15). DOI:10.1200/JCO.2021.39.15_suppl.5024.

Falco A, de Oliveira TB, Cacicedo J, Ospina AV, Ticona MA, Galindo H et al. Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice. Cancer Manag Res. 2021; 13: 6689-6703. DOI:10.2147/CMAR.S322411.

Canon V, Gomez Iturriaga A, Casquero F, Rades D, Navarro A, del Hoyo O et al. Quality of Life improvement in patients with bone metastases undergoing palliative radiotherapy. Radiother Oncol. 2021; 161: 722-724

Buchser D, Bilbal A, Mayrata E, Perez F, Espinosa JM, Valverde I et al. HDR-BT plus SBRT for prostate cancer. QoL and toxicity analysis in a prospective phase II trial. Radiother Oncol. 2021; 161: 39-640

Dal Pra A, Dirix P, Khoo V, Carrie C, Cozzarini C, Fonteyne V et al. ESTRO ACROP Guideline on Prostate Bed Delineation for Postoperative Radiotherapy in Prostate Cancer. Radiother Oncol. 2021; 161: 391-391

Chiesa C, Sjogreen Gleisner K, Walrand S, Strigari L, Flux G, Gear J et al. EANM dosimetry committee series on standard operational procedures: a unified methodology for Tc-99m-MAA pre- and Y-90 peri-therapy dosimetry in liver radioembolization with Y-90 microspheres. EJNMMI Phys. 2021; 8(1). DOI:10.1186/s40658-021-00394-3.

Gustafsson J, Minguez P. Modelling Aspects for Quantitative Monte Carlo-based SPECT Reconstruction of Radium-223. Eur J Nucl Med Mol Imaging. 2021; 48(SUPPL 1): 229-230

Munoz RN, Ortega YC, Sarmiento M, Jorge RV, Herrero MN, Subirats JG et al. Postoperative basal serum thyroglobuline (TG) prior to radioiodine therapy as a predictive factor of recurrence in patients with differentiated thyroid cancer (DTC). Eur J Nucl Med Mol Imaging. 2021; 48(SUPPL 1): 436-436

Pontes B, Nunez F, Rubio C, Moreno A, Nepomuceno I, Moreno J et al. A data mining based clinical decision support system for survival in lung cancer. Rep Pract Oncol Radiother. 2021; 26(6): 839-848. DOI:10.5603/RPOR.a2021.0088.

Zapatero A, Castro P, Roch M, Buchser D, de Vidales CM, Gonzalez S et al. VMAT Focal Boost to MRI-Defined Intraprostatic Lesion in Localized Prostate Cancer: Results of a Phase II Trial. Int J Radiat Oncol Biol Phys. 2021; 111(3): 298-298

Campos FL, Lorente D, Llacer Perez C, Henriquez I, Peleteiro P, Gomez Iturriaga A et al. Local treatment to the primary tumor and PSA changes as prognostic factors in mCRPC. Radiother Oncol. 2021; 161: 755-756

Campos FL, Lorente D, Perez CL, Gomez Iturriaga A, Henriquez Lopez I, Peleteiro P et al. PSA Progression and survival in mCRPC patients treated with abiraterone or enzalutamide. Radiother Oncol. 2021; 161: 750-751

Zapatero A, Roch M, Tejero PC, Buchser D, de Vidales CM, Gonzalez S et al. MRI-Guided focal boost to intraprostatic lesion using VMAT in prostate cancer. A Phase II Trial. Radiother Oncol. 2021; 161: 640-640

Fuertes TM, Iglesias NM, Llorente DA, Olmedo DS, Sanchez CA, Montes M et al. Dosimetry of Metastases in Treatments with Lu-177-DOTATATE - Comparison Between two Calculation Software. Eur J Nucl Med Mol Imaging. 2021; 48(SUPPL 1): 578-579

Wagstaff P, Gabina PM, Roeske J. Alpha Particle Microdosimetry Calculations Aided by Shallow Neural Network Regression Fitting. Med Phys. 2021; 48(6)

Gonzalez San Segundo C, Gomez Iturriaga A, Counago F. Are all prostate cancer patients ``fit'' for salvage radiotherapy?. World J Clin Oncol. 2020; 11(1): 1-10. DOI:10.5306/wjco.v11.i1.1.

Rades D, Cacicedo J, Conde Moreno AJ, Segedin B, But Hadzic J, Groselj B, et al. Precision radiotherapy for metastatic spinal cord compression: Final results of the PRE-MODE Trial. Int J Radiat Oncol Biol Phys. 2020; 106(4): 780-789. DOI:10.1016/j.ijrobp.2019.11.401.

Cacicedo J, Navarro Martin A, Gonzalez Larragan S, De Bari B, Salem A, Dahele M. Systematic review of educational interventions to improve contouring in radiotherapy. Radiother Oncol. 2020; 144: 86-92. DOI:10.1016/j.radonc.2019.11.004.

O'Sullivan JM, Carles J, Cathomas R, Gomez Iturriaga A, Heinrich D, Kramer G, et al. Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group. Eur Urol Oncol. 2020; 3(4): 471-479. DOI:10.1016/j.euo.2019.02.007.

De Bruycker A, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, et al. PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC Cancer. 2020; 20(1): 406-406. DOI:10.1186/s12885-020-06911-4.

Gomez Iturriaga A, Buchser D, Mayrata E, San Miguel I, Gonzalez A, Suarez F, et al. Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial. Radiother Oncol. 2020; 146: 16-20. DOI:10.1016/j.radonc.2020.01.025.

Gear J, Chiesa C, Lassmann M, Gabiña PM, Tran Gia J, Stokke C, et al. EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131 I mIBG treatment of neuroendocrine tumours. EJNMMI Phys. 2020; 7(1): 15-15. DOI:10.1186/s40658-020-0282-7.

Gutiérrez Zurimendi G, Llarena Ibarguren R, Lecumberri Castaños D, Fernández Pereda R, Urresola Olabarrieta A, García De Casasola Rodríguez G, et al. Metástasis pancreáticas de tumor primario renal: presentacion de una serie de casos y revisión de la literatura. Arch Esp Urol. 2020; 73(2): 147-154

Rades D, Narvaez CA, Doemer C, Janssen S, Olbrich D, Tvilsted S, et al. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis. Trials. 2020; 21(1). DOI:10.1186/s13063-020-04307-0.

Gustafsson J, Rodeno E, Minguez P. Feasibility and limitations of quantitative SPECT for Ra-223. Phys Med Biol. 2020; 65(8). DOI:10.1088/1361-6560/ab7971.

Counago F, Lopez Campos F, Diaz Gavela AA, Almagro E, Fenandez Pascual E, Henriquez I, et al. Clinical Applications of Molecular Biomarkers in Prostate Cancer. Cancers (Basel). 2020; 12(6). DOI:10.3390/cancers12061550.

Cacicedo J, Ciria JP, Morillo V, Martinez Indart L, Gomez Iturriaga A, Del Hoyo O, et al. Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study. J Med Imag Radiat Oncol. 2020; 64(6): 859-865. DOI:10.1111/1754-9485.13088.

de Miguel PA, Enguix Riego MV, Cacicedo J, Delgado BD, Perez M, Praena Fernandez JM, et al. Prognostic value of the TGF beta 1 rs4803455 single nucleotide polymorphism in small cell lung cancer. Tumori J. 2020; 107(3): 209-215. DOI:10.1177/0300891620946841.

Gomez Iturriaga A, Buchser D, Miguel IS, Marban M, Urresola A, Ezquerro A, et al. MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?. Clin Transl Radiat Oncol. 2020; 24: 135-139. DOI:10.1016/j.ctro.2020.08.002.

Pena Chilet M, Roldan G, Perez Florido J, Ortuno FM, Carmona R, Aquino V, et al. CSVS, a crowdsourcing database of the Spanish population genetic variability. Nucleic Acids Res. 2020; 49(D1): 1130-1137. DOI:10.1093/nar/gkaa794.

Minguez Gabina P, Roeske JC, Minguez R, Rodeno E, Gomez de Iturriaga A. Microdosimetry-based determination of tumour control probability curves for treatments with225Ac-PSMA of metastatic castration resistant prostate cancer. Phys Med Biol. 2020; 65(23): 235012-235012. DOI:10.1088/1361-6560/abbc81.

Manini C, Gonzalez A, Buchser D, Garcia Olaverri J, Urresola A, Ezquerro A, et al. Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. J Pers Med. 2020; 10(4): 1-9. DOI:10.3390/jpm10040265.

Fernandez Gonzalez L, Blanco Mata R, Garcia San Roman K, Orive Melero L, Vitoria Vallejo Y, Astorga Burgo JC, et al. Percutaneous Closure of Perforated Ventricular Septal Pseudoaneurysm With "Cribriform" Amplatzer Device Using 3D Modelling. JACC-Cardiovasc Interv. 2020; 13(23): 211-214. DOI:10.1016/j.jcin.2020.09.058.

Zilli T, Dirix P, Heikkila R, Liefhooghe N, Siva S, Gomez Iturriaga A, et al. The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. Eur Urol Focus. 2020; 7(2): 241-244. DOI:10.1016/j.euf.2020.12.010.

Minguez P, Rodeno E, Fernandez I, Esteban A, Martinez Indart L, de Iturriaga AG. A retrospective study on the potential of 99m Tc-HDP imaging before therapy for individualizing treatments with 223 Ra-Cl2 for metastatic castration resistant prostate cancer. Med Phys. 2020; 48(3): 1395-1403. DOI:10.1002/mp.14683.

de Miguel PA, Enguix Riego MV, Cacicedo J, Delgado BD, Perez M, Praena Fernandez JM, et al. Prognostic value of the TGF beta 1 rs4803455 single nucleotide polymorphism and its association with prophylactic cranial irradiation in small cell lung cancer. J Clin Oncol. 2020; 38(15)

Gonzalez San Segundo C, Counago F, Gomez Iturriaga A. Androgen Deprivation Therapy and Salvage Radiotherapy: Are We Missing Something?. Eur Urol. 2019; 76(2): 260-261. DOI:10.1016/j.eururo.2019.01.045.

Rades D, Motisi L, Veninga IT, Conde Moreno A, Cacicedo J, Schild SE. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer. Clin Lung Cancer. 2019; 20(4): 322-329. DOI:10.1016/j.cllc.2019.04.005.

del Valle Enguix Riego M, Cacicedo J, Delgado Leon BD, Nieto Guerrero Gomez JM, Herrero Rivera D, Perez M, et al. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation. Radiother Oncol. 2019; 136: 29-36. DOI:10.1016/j.radonc.2019.03.025.

Genolla J, Rodriguez T, Minguez P, Lopez Almaraz R, Llorens V, Echebarria A. Dosimetry-based high-activity therapy with I-131-metaiodobenzylguanidine (I-131-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma. Eur J Nucl Med Mol Imaging. 2019; 46(7): 1567-1575. DOI:10.1007/s00259-019-04291-x.

David Delgado B, Valle Enguix Riego M, Fernandez de Bobadilla JC, Herrero Rivera D, Nieto Guerrero Gomez JM, Manuel Praena Fernandez J, et al. Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer. Radiother Oncol. 2019; 135: 161-169. DOI:10.1016/j.radonc.2019.03.005.

San Miguel I, Buchser D, Suarez F, Casquero F, Fernandez I, Rodeno E, et al. Pattern of Relapse After Metastases Directed Therapy in Oligorrecurrent Prostate Cancer. Radiother Oncol. 2019; 133(1): 446-446

Gabilondo I, Llorens V, Rodriguez T, Fernandez M, Perez Concha T, Acera M, et al. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders. Eur J Nucl Med Mol Imaging. 2019; 46(2): 376-384. DOI:10.1007/s00259-018-4183-0.

Otero Garcia Ramos B, Urresola A, Diez Garcia J, Rodeno E, Alonso Sanchez I. SURGICAL STAGING OF ADVANCED CERVICAL CANCER. Br J Surg. 2019; 106(2): 10-10

Gomez Iturriaga A, Buchser D, Minguez P, Espinosa JM, Perez F, Cacicedo J, et al. Pattern of relapse and dosimetric analysis of a single dose 19Gy HDR-brachytherapy phase II trial. Radiother Oncol. 2019; 133(1): 140-140. DOI:10.1016/S0167-8140(19)30703-0.

Lancia A, Zilli T, Achard V, Dirix P, Everaerts W, Gomez Iturriaga A, et al. Oligometastatic prostate cancer: The game is afoot. Cancer Treat Rev. 2019; 73: 84-90. DOI:10.1016/j.ctrv.2019.01.005.

Buechser D, Casquero F, Espinosa JM, Perez F, Minguez P, Martinez Indart L, et al. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study. Radiother Oncol. 2019; 135: 13-18. DOI:10.1016/j.radonc.2019.02.018.

Buchser D, Casquero F, Espinosa JM, Perez F, Minguez P, Martinez Indart L, et al. Late toxicity after single dose HDR-BT and EBRT for prostate cancer: clinical-dosimetric predictors. Radiother Oncol. 2019; 133(1): 1191-1191. DOI:10.1016/S0167-8140(19)32573-3.

Gonzalez San Segundo C, Jove J, Zapatero A, Pastor Peidro J, Vazquez ML, Casana M, et al. Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes. Clin Transl Oncol. 2019; 21(8): 1044-1051. DOI:10.1007/s12094-018-02021-7.

Manzardo C, Londono MC, Castells L, Testillano M, Luis Montero J, Penafiel J, et al. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018). Am J Transplant. 2019; 19(2): 614-614. DOI:10.1111/ajt.15244.

Rades D, Segedin B, Conde Moreno AJ, Ferrer Albiach C, Metz M, Polat B, et al. Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy x 5 to 3 Gy x 10 for Metastatic Epidural Spinal Cord Compression. Int J Radiat Oncol Biol Phys. 2019; 105(4): 760-764. DOI:10.1016/j.ijrobp.2019.08.002.

Gomez Iturriaga A, Casquero Ocio F, Ost P, Fernandez I, Rodeno E, Llarena R, et al. Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT. Eur J Cancer Care. 2019; 28(5). DOI:10.1111/ecc.13093.

Minguez Gabina P, de Iturriaga Pina AG, Esteban Figueruelo A, Nevares Herrero M, Valverde Jorge R, Fernandez Tercero I, et al. Correlation between lesion absorbed dose and relative variation of the Tc-99m-HDP lesion uptake before the first cycle and after the sixth cycle in patients treated for metastatic castration resistant prostate cancer with Ra-223. Eur J Nucl Med Mol Imaging. 2019; 46: 363-364

Nevares Herrero M, Minguez Gabina P, Esteban Figueruelo A, Valverde Jorge R, Fernandez Tercero I, Ortiz de Zarate ER, et al. Initial Evaluation of the Protocol to Assess the Function of Future Remnant Liver After Major Hepatectomy by Means of Hepatobiliary Scintigraphy and SPECT/CT Imaging with 99mTc-Mebrofenin. Eur J Nucl Med Mol Imaging. 2019; 46(SUPPL 1): 246-247

Lopez Torrecilla J, Marin i Borras S, Ruiz Alonso A, Jaen Olasolo J, Vazquez de la Torre ML, Boveda Carro E, et al. Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology. Clin Transl Oncol. 2019; 21(4): 519-533. DOI:10.1007/s12094-018-1943-z.

Minguez P, Rodeno E, Genolla J, Dominguez M, Exposito A, Gleisner KS. Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of I-131-NaI respectively. Phys Medica. 2019; 65: 143-149. DOI:10.1016/j.ejmp.2019.08.017.

Rades D, Hansen O, Jensen LH, Dziggel L, Staackmann C, Doemer C, et al. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study. BMC Cancer. 2019; 19(1): 1163-1163. DOI:10.1186/s12885-019-6390-x.

Conde Moreno AJ, Lopez F, Hervas A, Piquer Camanes T, Mendez A, Puertas MDM, et al. Phase II Trial of SBRT and Hormone Therapy for Oligometastases in Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019; 105: 149-150. DOI:10.1016/j.ijrobp.2019.06.155.

Herrero Rivera D, Nieto Guerrero Gómez JM, Cacicedo Fernández de Bobadilla J, Delgado D, Rivin Del Campo E, Praena Fernández JM, et al. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment. Clin Transl Oncol. 2019; 21(9): 1220-1230. DOI:10.1007/s12094-019-02047-5.

De Bleser E, Jereczek Fossa BA, Pasquier D, Zilli T, Van As N, Siva S, et al. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. Eur Urol. 2019; 76(6): 732-739. DOI:10.1016/j.eururo.2019.07.009.

Lopez Campos F, Gomez Iturriaga A, Llacer Perez C, Henriquez I, Peleteiro P, Lozano R, et al. Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer. J Clin Oncol. 2019; 37. DOI:10.1200/JCO.2019.37.15_suppl.e16530.

Espejo Nino J, Nevares Herrero M, Valverde Jorge R, Cobos Baena P, Andres Alvarez L, Rodeno Ortiz de Zarate E. Sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (A-NAC) in patients with locally advanced breast cancer (LABC). Preliminary results before validation of the technique. Eur J Nucl Med Mol Imaging. 2019; 46: 523-523

Rodriguez A, Arenas M, Lara PC, Lopez Torrecilla J, Algara M, Conde A, et al. Are there enough radiation oncologists to lead the new Spanish radiotherapy?. Clin Transl Oncol. 2019; 21(12): 1663-1672. DOI:10.1007/s12094-019-02095-x.

Gomez Iturriaga A, Casquero F, Pijoan JI, Minguez P, Espinosa JM, Irasarri A, et al. Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial. Radiother Oncol. 2018; 126(2): 278-282. DOI:10.1016/j.radonc.2017.10.039.

Minguez P, de Iturriaga AG, Fernandez IL, Rodeno E. Detection and quantification of Ra-223 uptake in bone metastases of patients with castration resistant prostate carcinoma, with the aim of determining the absorbed dose in the metastases. Rev Esp Med Nucl Imagen Mol. 2018; 37(1): 20-27. DOI:10.1016/j.remn.2017.04.009.

Gonzalez C, Jove Teixido J, Zapatero A, Peidro JP, de la Torre MLV, Casana M, et al. Survival after Biochemical Failure in Prostate Cancer Treated with Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018; 102(3): 113-113. DOI:10.1016/j.ijrobp.2018.07.309.

San Miguel I, Buchser D, Suarez F, Casquero F, Fernandez I, Rodeno E, et al. Pattern of Relapse after Metastases Directed Therapy in Patients with Oligorecurrent Prostate Cancer Detected with Choline PET-CT. Int J Radiat Oncol Biol Phys. 2018; 102(3): 164-164. DOI:10.1016/j.ijrobp.2018.07.021.

Counago F, Sancho G, Gomez Iturriaga A, Henriquez I, Urological Tumours WO. Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain. Clin Transl Oncol. 2018; 20(11): 1484-1491. DOI:10.1007/s12094-018-1919-z.

Minguez P, Roeske JC, Minguez R, de Iturriaga AG, Rodeno E. Comparison of microdosimetry-based absorbed doses to control tumours and clinically obtained tumour absorbed doses in treatments with Ra-223. Phys Med Biol. 2018; 63(14). DOI:10.1088/1361-6560/aacdcc;145005.

Barbier L, Ramos E, Mendiola J, Rodriguez O, Santamaria G, Santamaria J, et al. Autologous dental pulp mesenchymal stem cells for inferior third molar post-extraction socket healing: A split-mouth randomised clinical trial. Med Oral Patol Oral Cir Bucal. 2018; 23(4): 469-477. DOI:10.4317/medoral.22466.

Nagore G, Guerra JLL, Krumina E, Lagos M, Ovalles B, Miro A, et al. High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions. Radiother Oncol. 2018; 127(2): 219-224. DOI:10.1016/j.radonc.2018.03.022.

Gomez Iturriaga A, Casquero F, Buchser D, Minguez P, Espinosa J, Perez F, et al. Clinical outcomes of HDR-prostate brachytherapy 19Gy single fraction: prospective phase II trial. Radiother Oncol. 2018; 127(1): 147-147. DOI:10.1016/S0167-8140(18)30596-6.

Margallo L, de Zarate EO, Franco M, Garcia Iruretagoyena M, Cherro R, Barbier L, et al. Lingual Artery Pseudoaneurysm after Severe Facial Trauma. Craniomaxillofacial Trauma Reconstr. 2018; 11(3): 219-223. DOI:10.1055/s-0037-1603454.

Gomez Iturriaga A, Casquero F, Pijoan JI, Crook J, Urresola A, Ezquerro A, et al. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018; 101(5): 1172-1178. DOI:10.1016/j.ijrobp.2018.04.039.

Counago F, Artigas C, Sancho G, Gomez Iturriaga A, Gomez Caamano A, Maldonado A, et al. Importance of Ga-68-PSMA PET/CT in hospital practice. View of the radiation oncologist. Rev Esp Med Nucl Imagen Mol. 2018; 37(5): 302-314. DOI:10.1016/j.remn.2018.07.005.

Cacicedo J, Gomez Iturriaga A, Navarro A, Morillo V, Willisch P, Lopez Guerra JL, et al. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?. J Med Imag Radiat Oncol. 2018; 62(4): 578-584. DOI:10.1111/1754-9485.12749.

Rades D, Conde Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, et al. A scoring system to predict local progression-free survival in patients irradiated with 20Gy in 5 fractions for malignant spinal cord compression. Radiat Oncol. 2018; 13. DOI:10.1186/s13014-018-1203-y.

Navarro Martin A, Galiana IL, Frances M, Cacicedo J, Cortes RC, Anton SC, et al. Preliminary Study of the Effect of Stereotactic Body Radiotherapy (SBRT) on the Immune System in Lung Cancer Patients Unfit for Surgery: Immunophenotyping Analysis. Int J Mol Sci. 2018; 19(12). DOI:10.3390/ijms19123963.

Rades D, Sondermann L, Motisi L, Janssen S, Cacicedo J, Schild SE. Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder. Anticancer Res. 2018; 38(12): 6841-6846. DOI:10.21873/anticanres.13058.

Gomez Iturriaga A, Crook J. High-Risk Localized Prostate Cancer: How Important Is the Addition of Brachytherapy to External-Beam Radiotherapy?. J Clin Oncol. 2018; 36(33): 3344-3344. DOI:10.1200/JCO.18.00704.

Rivera S, Petit C, Martin AN, Cacicedo J, Leaman O, Rosselot M, et al. Long-term impact on contouring skills achieved by online learning. An ESTRO-FALCON-IAEA study. Int J Radiat Oncol Biol Phys. 2018; 102(3): 397-397. DOI:10.1016/j.ijrobp.2018.07.1174.

Nino JE, Herrero MN, Figueruelo AE, Salmon MS, De Zarate E. Our Performance In Sentinel Lymph Node Biopsy (SLNB) After Neoadyuvant Chemotherapy In Patients With Locally Advanced Breast Cancer (LABC) Diagnosis. Eur J Nucl Med Mol Imaging. 2018; 45(1): 431-431

Gustafsson J, Minguez P. The Potential for Quantitative SPECT of Ra-223 - A Monte Carlo Study. Eur J Nucl Med Mol Imaging. 2018; 45(1): 295-295

Rodriguez JC, Cacicedo J, Giralt J, Miragall EG, Lloret M, Arias F, et al. GEORCC recommendations on target volumes in radiotherapy for Head Neck Cancer of Unkown Primary. Crit Rev Oncol Hematol. 2018; 130: 51-59. DOI:10.1016/j.critrevonc.2018.07.006.

Hervas A, Gomez Caamano A, Casana M, Gomez Iturriaga A, Pastor J, Jove J, et al. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database. Clin Transl Oncol. 2018; 20(2): 193-200. DOI:10.1007/s12094-017-1709-z.

Rades D, Conde Moreno AJ, Cacicedo J, Segedin B, Stanic K, Metz M, et al. Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial. Anticancer Res. 2018; 38(2): 1009-1015. DOI:10.21873/anticanres.12316.

Rades D, Conde Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, et al. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups. Radiat Oncol. 2018; 13. DOI:10.1186/s13014-018-0968-3.

Algara M, Lopez Guerra J, Flaquer A, Beato I, Martinez F, Rodriguez J, et al. Incidental or intentional node irradiation in breast cancer. Preliminary results of OPTIMAL Trial. Radiother Oncol. 2018; 127(1): 714-714. DOI:10.1016/S0167-8140(18)31611-6.

Ayala P, Cacicedo J, Delgado D, Nieto Guerrero JM, Herrero D, Praena JM, et al. Prognostic value of PCI and single nucleotide polymorphism rs4803455 of TGF beta 1 gene in SCLC. Radiother Oncol. 2018; 127(1): 1272-1273. DOI:10.1016/S0167-8140(18)32615-X.

Buchser D, Gomez Iturriaga A, Casquero F, Urresola A, Ezquerro A, Cacicedo J, et al. Pre-treatment mpMRI accuracy and prognostic value in intermediate risk localized prostate cancer. Radiother Oncol. 2018; 127(1): 867-868

Carvajal C, Cacicedo J, Casquero F, Canteli B, Urresola A. Utility of Magnetic Resonance imaging in the diagnosis of Radiation osteitis in sarcoma patients. Radiother Oncol. 2018; 127(1): 909-909. DOI:10.1016/S0167-8140(18)32002-4.

Moreno AC, Campos FL, Moron AH, Ocana CV, Albarran JV, Villamon AM, et al. Phase II trial of SBRT and Hormone therapy for Oligometastases in Prostate Cancer (SBRT-SG 05). Radiother Oncol. 2018; 127(1): 27-28

Delgado Leon BD, Enguix MV, Cacicedo J, Nieto Guerrero JM, Herrero D, Praena JM, et al. SNPs at rs7459185 and rs11466353 of the TGF ss 1 Gene are associated with esophagitis in lung cancer. Radiother Oncol. 2018; 127(1): 304-304. DOI:10.1016/S0167-8140(18)30891-0.

Eriksen JG, Cacicedo J, Navarro Martin A, Petit C, Rosselot M, Lazaryan A, et al. Long-term impact on contouring skills can be achieved by online learning. An ESTRO-FALCON-IAEA study. Radiother Oncol. 2018; 127(1): 452-453. DOI:10.1016/S0167-8140(18)31174-5.

Guerra JLL, Pontes B, Moreno A, Rubio C, Nunez F, Nepomuceno I, et al. Project S32: decision support system for lung cancer patients. Radiother Oncol. 2018; 127(1): 449-450

Mohammed W, Hoskin P, Henry A, Gomez Iturriaga A, Robinson A, Nikapota A. Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease. Clin Oncol. 2018; 30(9): 534-538. DOI:10.1016/j.clon.2018.06.007.

Campos FL, Moreno I, Conde Moreno A, Gomez Iturriaga A, Vico MR, Laorden NR, et al. Prognostic associations of early prostate-specific antigen (PSA) changes in patients with metastatic castration-resistant prostate cancer treated with with abiraterone acetate or enzalutamide. Ann Oncol. 2018; 29(8): 285-285

Rivera DH, Gomez JMNG, De Bobadilla JCF, Delgado DB, Mejias A, Soler JJG, et al. Cardiovascular disease and survival in lung cancer: a multicenter prospective assessment. Radiother Oncol. 2018; 127(1): 746-746

Enguix Riego M, de Bobadilla JCF, Rivera DH, Delgado D, Gomez JNG, Soler JG, et al. Multicenter prospective validation of HSPB1 rs2868371 SNP and survival in non-small cell lung cancer. Radiother Oncol. 2018; 127(1): 77-77. DOI:10.1016/S0167-8140(18)30463-8.

Gomez JMNG, de Bobadilla JCF, Leon BDD, Rivera DH, Perea EM, Fernandez JMP, et al. Pre-radiotherapy quality of live assessment predicts survival in lung cancer patients. Radiother Oncol. 2018; 127(1): 750-751

Gomez Iturriaga A, Casquero F, Lopez JI, Urresola A, Ezquerro A, Buscher D, et al. Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision. Brachytherapy. 2017; 16(1): 201-206. DOI:10.1016/j.brachy.2016.11.004.

Rades D, Veninga T, Conde Moreno AJ, Cacicedo J, Metz M, Šegedin B, et al. Results of a multicenter study investigating the potential impact of the overall treatment time on outcomes of radiation therapy alone with 5x4 Gy for metastatic epidural spinal cord compression. Pract Radiat Oncol. 2017; 7(2): 137-144. DOI:10.1016/j.prro.2016.07.005.

Rades D, Janssen S, Conde Moreno AJ, Cacicedo J, Metz M, Veninga T, et al. Role of the overall treatment time of radiotherapy with 10x3Gy for outcomes in patients with metastatic spinal cord compression. J Med Imag Radiat Oncol. 2017; 61(3): 388-393. DOI:10.1111/1754-9485.12553.

Cacicedo J, Fernandez I, del Hoyo O, Navarro A, Gomez Iturriaga A, Ignacio Pijoan J, et al. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Clin Transl Oncol. 2017; 19(11): 1337-1349. DOI:10.1007/s12094-017-1674-6.

Gomez Iturriaga A, Casquero F, Pijoan JI, Ezquerro A, Urresola A, Minguez P, et al. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017; 99(2): 134-134. DOI:10.1016/j.ijrobp.2017.06.312.

Lopez Almaraz R, Echebarria Barona A, Gonzalez Camacho U, De Pedro Olabarri JM, Garcia Ariza M, Adan Pedroso R, et al. PET/TC Utility in the Assessment of the Response to Treatment in Pediatric Lymphomas. Pediatr Blood Cancer. 2017; 64(3): 443-444

Lopez Almaraz R, Garcia Ariza M, De Pedro Olabarri JM, Gonzalez Camacho U, Echebarria Barona A, Adan Pedroso R, et al. Value of PET/CT in Treatment Response to Chemotherapy in Musculoskeletal Tumors. Pediatr Blood Cancer. 2017; 64(3): 406-406

Garcia L, Azorin JFP, Aguilar Redondo PB, Moran Velasco V. Improving the gamma analysis comparison using an unbinned multivariate test. Phys Med Biol. 2017; 62(18): 417-427. DOI:10.1088/1361-6560/aa848f.

Rueda A, Giralt J, Manos M, Lozano A, Sistiaga A, Garcia Miragall E, et al. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2). Oral Oncol. 2017; 70: 65-72. DOI:10.1016/j.oraloncology.2017.04.005.

Mohammed W, Henry A, Gomez Iturriaga A, Nikapota A. Short-term Clinical Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease. Clin Oncol. 2017; 29(3): 86-86. DOI:10.1016/j.clon.2016.11.014.

Barquero R, Garcia HP, Incio MG, Minguez P, Cardenas A, Martinez D, et al. I-131 activity quantification of gamma camera planar images. Phys Med Biol. 2017; 62(3): 909-926. DOI:10.1088/1361-6560/62/3/909.

Olasolo Alonso J, Vazquez Galinanes A, Pellejero S, Perez Azorin JF. Evaluation of MLC performance in VMAT and dynamic IMRT by log file analysis. Phys Medica. 2017; 33: 87-94. DOI:10.1016/j.ejmp.2016.12.013.

Gleisner KS, Spezi E, Solny P, Gabina PM, Cicone F, Stokke C, et al. Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey. EJNMMI Phys. 2017; 4. DOI:10.1186/s40658-017-0193-4.

Rades D, Cacicedo J, Conde Moreno AJ, Doemer C, Dunst J, Lomidze D, et al. High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study. BMC Cancer. 2017; 17. DOI:10.1186/s12885-017-3844-x.

Stokke C, Gabina PM, Solny P, Cicone F, Sandstrom M, Gleisner KS, et al. Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force. EJNMMI Phys. 2017; 4. DOI:10.1186/s40658-017-0194-3.

Sagasta Urrutia J, Portilla Quattrociocchi H, Garcia Hernandez D, Montero de la Peña A, Moreno Capdevila C, Tobalina Larrea I. Atypical location of metastatic ovarian carcinoma detected by F-18-FDG PET/CT. Rev Esp Med Nucl Imagen Mol. 2016; 35(1): 58-60. DOI:10.1016/j.remn.2015.07.010.

Perez Azorin JF, Ramos Garcia LI, Maza Ozcoidi D, Almansa JF. Polarized dosimetry method for Gafchromic EBT3. Phys Medica. 2016; 32(8): 972-980. DOI:10.1016/j.ejmp.2016.06.013.

Rouco I, Arostegui J, Canovas A, Gonzalez del Tanago J, Fernandez I, Zarranz JJ. Neurological manifestations in Erdheim-Chester disease: Two case reports. Neurologia. 2016; 31(6): 426-428. DOI:10.1016/j.nrl.2014.01.010.

Navarro Martin A, Aso S, Cacicedo J, Arnaiz M, Navarro V, Rosales S, et al. Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months. J Thorac Oncol. 2016; 11(7): 1101-1111. DOI:10.1016/j.jtho.2016.03.021.

Rades D, Conde Moreno AJ, Segedin B, Veninga T, Cacicedo J, Schild SE. A Prognostic Instrument to Estimate the Survival of Elderly Patients Irradiated for Metastatic Epidural Spinal Cord Compression From Lung Cancer. Clin Lung Cancer. 2016; 17(4): 279-284. DOI:10.1016/j.cllc.2015.10.001.

Gomez Iturriaga A, Casquero F, Urresola A, Ezquerro A, Lopez JI, Espinosa JM, et al. Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial. Radiother Oncol. 2016; 119(1): 91-96. DOI:10.1016/j.radonc.2016.02.004.

Rades D, Conde Moreno AJ, Cacicedo J, Segedin B, Rudat V, Schild SE. Radiation Therapy Alone Provides Excellent Outcomes for Spinal Cord Compression from Vertebral Lymphoma. Anticancer Res. 2016; 36(6): 3081-3083

Delgado A, Mesa J, Guayambuco S, Rodriguez T, Fernandez I, Rodeno E. PET/CT imaging with F-18-FDG in Castleman disease. Rev Esp Med Nucl Imagen Mol. 2016; 35(3): 200-201. DOI:10.1016/j.remn.2015.10.001.

Rades D, Jose Conde Moreno A, Cacicedo J, Veninga T, Gebauer N, Bartscht T, et al. A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression. BMC Cancer. 2016; 16: 292-292. DOI:10.1186/s12885-016-2325-y.

De Bari B, Franco P, Niyazi M, Cornetto AP, Qvortrup C, Navarro Martin A, et al. The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?. Technol Cancer Res Treat. 2016; 15(2): 365-376. DOI:10.1177/1533034615572287.

Minguez P, Gustafsson J, Flux G, Gleisner KS. Biologically effective dose in fractionated molecular radiotherapy-application to treatment of neuroblastoma with I-131-mIBG. Phys Med Biol. 2016; 61(6): 2532-2551. DOI:10.1088/0031-9155/61/6/2532.

Rades D, Segedin B, Conde Moreno AJ, Garcia R, Perpar A, Metz M, et al. Radiotherapy With 4 Gy X 5 Versus 3 Gy X 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01). J Clin Oncol. 2016; 34(6): 597-597. DOI:10.1200/JCO.2015.64.0862.

Ramos Garcia LI, Perez Azorin JF, Almansa JF. A new method to measure electron density and effective atomic number using dual-energy CT images. Phys Med Biol. 2016; 61(1): 265-279. DOI:10.1088/0031-9155/61/1/265.

Rades D, Conde Moreno AJ, Gebauer N, Bartscht T, Cacicedo J, Segedin B, et al. Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma. Anticancer Res. 2016; 36(1): 375-378

Rades D, Conde Moreno AJ, Cacicedo J, Szegedin B, Schild SE. Estimating the Survival of Elderly Patients with Renal Cell Carcinoma Presenting with Malignant Spinal Cord Compression. Anticancer Res. 2016; 36(1): 409-413

Gomez Iturriaga A, Casquero F, Fernandez I, Rodeno E, Urresola A, Ezquerro A, et al. Outcomes After a First and/or Second Salvage Treatment in Patients With Oligometastatic Prostate Cancer Recurrence Detected by (18-F) Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2016; 96(2): 250-250. DOI:10.1016/j.ijrobp.2016.06.1250.

Olarte A, Gomez Iturriaga A, Fernandez I, Casquero F, Cacicedo J, Urresola A, et al. Salvage Treatment in Patients With Prostate Cancer Oligorecurrence: Impact of 18-F-Fluorocholine Positron Emission Tomography/Computed Tomography on Clinical Decision Making. Int J Radiat Oncol Biol Phys. 2016; 96(2): 224-225. DOI:10.1016/j.ijrobp.2016.06.1153.

Minguez P, Flux G, Genolla J, Delgado A, Rodeno E, Gleisner KS. Whole-remnant and maximum-voxel SPECT/CT dosimetry in I-131-NaI treatments of differentiated thyroid cancer. Med Phys. 2016; 43(10): 5279-5287. DOI:10.1118/1.4961742.

Gomez Iturriaga A, Cabeza A, Pastor J, Jove J, Casana M, Caamano AG, et al. The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort. Clin Transl Oncol. 2016; 18(10): 1026-1033. DOI:10.1007/s12094-016-1481-5.

Rades D, Conde Moreno AJ, Cacicedo J, Segedin B, Rudat V, Schild SE. Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma. Radiol Oncol. 2016; 50(3): 337-340. DOI:10.1515/raon-2016-0029.

Isaac Ramos Garcia L, Fernando Perez Azorin J, Almansa JF. Reply to Comment on 'A new method to measure electron density and effective atomic number using dual-energy CT images'. Phys Med Biol. 2016; 61(16): 6266-6268. DOI:10.1088/0031-9155/61/16/6266.

Cacicedo J, Navarro A, del Hoyo O, Gomez Iturriaga A, Along F, Medina JA, et al. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. Br J Radiol. 2016; 89(1067): 20160217-20160217. DOI:10.1259/bjr.20160217.

Fernandez Tercero IL, Gomez Iturriaga A, Sanchez Salmon A, Casquero F, Urresola A, Ezquerro AI, et al. Impact of 18F-Choline PET-CT on the selection of patients with oligometastatic prostate cancer recurrence candidates for local salvage treatments. Eur J Nucl Med Mol Imaging. 2016; 43(1): 339-339

Buchser D, Gomez Iturriaga A, Rodriguez Melcon JI, Casquero F, Llarena R, Cacicedo J, et al. Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy. J Contemp Brachytherapy. 2016; 8(6): 477-483. DOI:10.5114/jcb.2016.64441.

Cacicedo J, Fernandez I, del Hoyo O, Gomez Iturriaga A, Martinez Indart L, Frias A, et al. Prognostic Value of Maximum Standardized Uptake Value Measured by Pretreatment 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinoma: Adding Value to Clinical Staging. Int J Radiat Oncol Biol Phys. 2016; 96(2, S): 383-383

Dominguez Ayala M, Minguez Gabina P, Exposito Rodriguez A, Ortiz de Zarate ER, Gutierrez Rodriguez T, Barrios Trevino B, et al. BRAF V600E Mutation In Papillary Thyroid Cancer: Its Influence On Radioiodine Postsurgical Therapy - Preliminary Results. Eur J Nucl Med Mol Imaging. 2016; 43(1): 157-157

Cacicedo J, Navarro A. Diagnostic performance of [18F] fluorodeoxyglucose PET/CT and diffusion-weighted magnetic resonance imaging for the evaluation of treatment response to induction chemotherapy followed by definitive chemoradiotherapy in locally advanced head and neck squamous cell carcinoma. Transl Cancer Res. 2016; 5(4): 823-826. DOI:10.21037/tcr.2016.10.32.

López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, et al. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]. Rep Pract Oncol Radiother. 2016; 21(1): 90-92. DOI:10.1016/j.rpor.2015.06.006.

Cacicedo J, Perez JF, Ortiz de Zarate R, del Hoyo O, Casquero F, Gomez Iturriaga A, et al. A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients. Clin Transl Oncol. 2015; 17(2): 113-120. DOI:10.1007/s12094-014-1200-z.

Carvajal C, Navarro Martin A, Cacicedo J, Ramos R, Guedea F. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results. J BUON. 2015; 20(1): 158-165

Cacicedo J, Dal Pra A, Alongi F, Navarro A. Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective. Eur J Clin Nutr. 2015; 69(7): 757-760. DOI:10.1038/ejcn.2015.65.

Navarro Martin A, Cacicedo J, Leaman O, Sancho I, Garcia E, Navarro V, et al. Comparative analysis of thermoplastic masks versus vacuum cushions in stereotactic body radiotherapy. Radiat Oncol. 2015; 10. DOI:10.1186/s13014-015-0484-7.

Rades D, Conde AJ, Garcia R, Cacicedo J, Segedin B, Perpar A, et al. A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer. Radiat Oncol. 2015; 10. DOI:10.1186/s13014-015-0483-8.

Ramos L, Perez Azorin JF. Comment on "A protocol for EBT3 radiochromic film dosimetry using reflection dosimetry using scanning" [Med. Phys. 41(12), 122101 (6pp.) (2014)]. Med Phys. 2015; 42(4): 2096-2097. DOI:10.1118/1.4914853.

Minguez P, Flux G, Genolla J, Guayambuco S, Delgado A, Cruz Fombellida J, et al. Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with I-131-metaiodobenzylguanidine with implications for the activity to administer. Med Phys. 2015; 42(7): 3969-3978. DOI:10.1118/1.4921807.

Adan R, Rubio R, Udaondo J, Lopez Macias O, Echebarria A, Lopez Almaraz R, et al. I131 META-IODOBENZYLGUANIDINE THERAPY IN CHILDREN WITH ADVANCE NEUROBLASTOMA. THE EXPERIENCE OF A HOSPITAL. Pediatr Blood Cancer. 2015; 62(4): 326-326

Gomez Iturriaga A, Cacicedo J, Navarro A, Morillo V, Willisch P, Carvajal C, et al. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study. BMC Palliat Care. 2015; 14. DOI:10.1186/s12904-015-0045-8.

Rades D, Conde Moreno AJ, Cacicedo J, Segedin B, Veninga T, Schild SE. Metastatic Spinal Cord Compression: A Survival Score Particularly Developed for Elderly Prostate Cancer Patients. Anticancer Res. 2015; 35(11): 6189-6192

Rades D, Huttenlocher S, Segedin B, Perpar A, Conde AJ, Garcia R, et al. Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis. Int J Radiat Oncol Biol Phys. 2015; 93(2): 368-372. DOI:10.1016/j.ijrobp.2015.05.042.

Cacicedo J, Fernandez I, del Hoyo O, Dolado A, Gomez Suarez J, Hortelano E, et al. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis. Eur J Nucl Med Mol Imaging. 2015; 42(9): 1378-1389. DOI:10.1007/s00259-015-3071-0.

López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, et al. Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance. Rep Pract Oncol Radiother. 2015; 20(4): 259-272. DOI:10.1016/j.rpor.2015.04.003.

Nathali Rivas Zavaleta M, Guayambuco Romero S, Calabozo Raluy M, Pérez Ruiz F. Osteomalacia induced by adefovir in patient with hepatitis B. Reumatol Clin. 2014; 10(2): 120-121. DOI:10.1016/j.reuma.2013.01.006.

Cacicedo Fernandez de Bobadilla J, Bilbao P. Do patients with head and neck human papillomavirus-related carcinoma need a different treatment approach?. Int J Clin Oncol. 2014; 19(4): 767-768. DOI:10.1007/s10147-013-0600-3.

Cacicedo J, Navarro A, Alongi F, Gómez de Iturriaga A, Del Hoyo O, Boveda E, et al. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treat Rev. 2014; 40(1): 178-189. DOI:10.1016/j.ctrv.2013.08.002.

Cacicedo J, Casquero F, Martinez Indart L, del Hoyo O, Gomez de Iturriaga A, Navarro A, et al. A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy. Chin J Cancer. 2014; 33(4): 204-210. DOI:10.5732/cjc.013.10009.

Perez Azorin JF, Ramos Garcia LI, Marti Climent JM. A method for multichannel dosimetry with EBT3 radiochromic films. Med Phys. 2014; 41(6): 62101-62101. DOI:10.1118/1.4871622.

Gomez Iturriaga A, Crook J, Casquero F, Carvajal C, Urresola A, Canteli B, et al. Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy. J Contemp Brachytherapy. 2014; 6(2): 154-160. DOI:10.5114/jcb.2014.43299.

IG, LGC, RFG. Nuevas técnicas IMRT para dianas en movimiento. Análisi d esu seguridad y efectividad. Nuevas Técnicas IMRT para dianas en movimientoAnálisis de su seguridad y efectividad. 2014

Cacicedo J, Bilbao P. Stereotactic body radiotherapy: An attractive treatment modality for recurrent head and neck carcinoma. (Regarding Lartigau et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer). Radiother Oncol. 2014; 111(3): 482-483. DOI:10.1016/j.radonc.2014.01.028.

Gomez Iturriaga A, Cacicedo J, Navarro A, Casquero F, Carvajal C, Morillo V, et al. Incidence of Pain Flare Following Palliative Radiation Therapy for Symptomatic Bone Metastases: Multicenter Prospective Observational Study. Int J Radiat Oncol Biol Phys. 2014; 90(1): 81-81. DOI:10.1016/j.ijrobp.2014.05.466.

Fernandez Tercero I, Sanchez Salmon A, Rodeno Ortiz de Zarate E, Delgado Quijano A, Urresola Olabarrieta A, Canteli Padilla B, et al. Importance of a proper selection of patients before performing a (18)FCholine PET/CT scan in the management of prostate cancer patients with biochemical relapse; preliminary results. Eur J Nucl Med Mol Imaging. 2014; 41(2): 388-388

Minguez Gabina F, Genolla Subirats J, Guayambuco Romero S, Delgado Quijano A, Roden Ortiz de Zaratel E, Gleisner KS. Prescription of activity in therapies with 131I and 131I-mIBG based on patient mass. Eur J Nucl Med Mol Imaging. 2014; 41(2): 238-238

Perez Azorin JF, Ramos Garcia LI, Marti Climent JM. Response to "Comment on 'A method for multichannel dosimetry with EBT3 radiochromic films' " [Med. Phys. 41, 062101 (10pp.) (2014)]. Med Phys. 2014; 41(10): 107102-107102. DOI:10.1118/1.4896179.

Hortelano E, Gomez Iturriaga A, Ortiz Zarate R, Zaballa M, Barturen A, Casquero F, et al. Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?. Rev Esp Enferm Dig. 2014; 106(3): 165-170

Cacicedo J, Del Hoyo O, Rodeno E, Fernandez I, Rodriguez O, Dolado A, et al. Utility Of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET/CT) in the Staging and Treatment Plan Evaluation of Head and Neck Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2014; 90(1): 552-552. DOI:10.1016/j.ijrobp.2014.05.1674.

Cacicedo J, Casquero F, Del Hoyo O, Gomez-Iturriaga A, Martinez-Indart L, et al. Definitive radiotherapy for T1 glottics quamous cell carcinoma: a 15-year Cruces University Hospital experience. Clin Transl Oncol. 2013;15:925-31 FI: 1,276(Q4)

Gomez-Iturriaga A, Cabeza M, Pastor J, Jove J, Casana M, Mengual J, et al. Multi-institutional Outcomes Following External Beam Radiation Therapy and Androgen Deprivation Therapy in Patients With Extreme-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2013;87:367. FI: 4,524(Q1)

Guayambuco S, Llorens V, Genollá J, Rodríguez T, Rodeño E, Fernández I, et al. Arterial pseudoaneurysm as a false positive forinfection in bonescintigraphy and with labelled leukocytes in a patient with total hip prosthesis. Rev Esp Med Nucl Imagen Mol. 2013;32:334-5.  FI: 0,863(Q4)

Cacicedo Fernandez de Bobadilla J, Bilbao P. Do patients with head and neck human papillomavirus-related carcinoma need a different treatment approach?. Int J Clin Oncol. 2013 Aug 6. [Epub ahead of print] FI: 1,727(Q3)

Lopez Jl, Cerda N, Caamano V, Larrinaga G, Gaafar A, Valenti C, et al. ERG, Ki-67, Gleason index and tumor volume correlations in transrectal core biopsies with prostate adenocarcinoma. Virchows Arch. 2013;463:332-3.FI: 2,676(Q2). ( Meeting Abstract).

Garcia LI, Azorin JF. Improving the calibration of radiochromic films by the use of uncertainties in optical density and dose. Med Phys. 2013;40:071726. FI: 2,911(Q1)

Cacicedo Fernandez de Bobadilla J. Re-irradiation for recurrent head and neck carcinomas (by Dr. Peponi et al). J BUON. 2013;18:802.FI: 0,761(Q4)

Rivas Zavaleta MN, Guayambuco Romero S, Calabozo Raluy M, Pérez Ruiz F. Osteomalacia induced by adefovir in patient with hepatitis B. ReumatolClin.  2013 May 7. pii: S1699-258X(13)00054-5. [Epub ahead of print]. FI: 0,000(Q0).

Mínguez P, Genolla J, Celeiro JJ, Fombellida JC. Dosimetry in differentiated thyroid carcinoma (12-1402R). Med Phys. 2013;40:012502. FI: 0,909(Q2)

Mínguez P, Genolla J, Celeiro J, Fombellida JC. Restriction periods for carers, comforters and members of the public in the treatment of hyperthyroidism. Radiat Prot Dosimetry. 2013;154:285-92. FI:0,909 (Q4)